[Skip to Content]
[Skip to Content Landing]
Contempo Updates
February 26, 2003

Current and Emerging Infectious Risks of Blood Transfusions

Author Affiliations

Author Affiliations: Blood Centers of the Pacific and University of California, San Francisco, and Blood Systems Inc, Scottsdale, Ariz (Dr Busch); Westat Inc, Rockville, Md, and University of British Columbia, Victoria (Dr Kleinman); and National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Nemo).

 

Contempo Updates Section Editor: Janet M. Torpy, MD, Contributing Editor, and Sarah Pressman Lovinger, MD, Fishbein Fellow.

JAMA. 2003;289(8):959-962. doi:10.1001/jama.289.8.959

The blood supply in the United States and other developed countries has never been as safe as it is now. During the past several decades, there have been dramatic progressive reductions in the risk of transfusion-transmitted clinically significant blood-borne infections. This has been accomplished as a result of extensive research to characterize transfusion-transmitted pathogens, development of strategies to measure infection rates in blood donor and recipient populations, characterization of the dynamics of early viremia, and implementation of progressively more restrictive donor eligibility criteria and increasingly sensitive laboratory screening methods.

First Page Preview View Large
First page PDF preview
First page PDF preview
×